These findings demonstrated that GOLM1 and FAM49B genes might be used as potential biomarkers to determine the development of HNSCC; moreover, GOLM1 and FAM49B can possibly be verified as prognostic indicators of HNSCC patients. Here, CYRIB is linked to head and neck squamous cell carcinoma.